About this trial
This study aims to test the feasibility and acceptability of a remotely delivered cue-based treatment intervention to promote smoking cessation among people who smoke lightly or non-daily. Secondary objectives include assessing preliminary efficacy on cessation and examining cue reactivity. Participants will be randomized to CBT only or CBT + cue-based treatment, with assessments at baseline, end-of-treatment, 6 months, and 12 months.
Eligibility criteria
Qualifiers
Age ≥18
Able to read and understand English or Spanish
Smoke 1-10 cigarettes/day on at least 4 days of the past two weeks for the last year
Willing to try quitting in next 30 days
Disqualifiers
Current participation in another smoking cessation study
Unable to provide consent
Refusal to abstain from e-cigarettes or other tobacco products
Use of medications affecting smoking cessation (e.g., Chantix, Wellbutrin)
Trial design
Treatments tested in this trial
- Cognitive Behavioral Therapy (CBT)
- Cue-based treatment intervention
Treatment groups
Locations
Sponsors and collaborators
Duke University
Lead sponsor
National Institutes of Health (NIH)
Collaborator
National Cancer Institute (NCI)
Collaborator
University of Oklahoma
Collaborator